Aman Kumar appointed as group chief financial officer of Innoterra

TAGS

Innoterra, a prominent Swiss-Indian food and technology platform company, has announced the promotion of Aman Kumar to the position of Group Chief Financial Officer (CFO), effective immediately. Aman Kumar, who joined Innoterra in January 2024 as the Deputy CFO, steps into his new role backed by a wealth of experience spanning 19 years in finance and strategy, including significant stints at startups and established businesses.

Aman Kumar’s Journey to CFO

Aman Kumar’s expertise as a Chartered Accountant and Chartered Financial Analyst has been instrumental in steering financial strategies at various organizations, from innovative startups like ePaylater and Workex to major corporate entities within the Tata Group. His transition to the role of Group CFO is seen as a strategic enhancement to Innoterra’s leadership team, aiming to bolster the company’s growth and governance.

See also  Nilesh Dalvi steps up as CFO of CreditAccess Grameen: What this means for the microfinance sector

Strategic Impact and Future Goals

As Group CFO, Aman Kumar is set to provide strategic financial leadership at Innoterra. His responsibilities will encompass driving growth initiatives, managing risks, and enhancing operational efficiency across the company’s global operations. Aman’s role will be crucial in navigating the opportunities and challenges within the agri-food industry, particularly as Innoterra looks to expand its technological and bioscience innovations to transform smallholder agriculture economics globally.

See also  PI Industries announces acquisition of Plant Health Care to boost sustainable agriculture solutions

Innoterra’s Commitment to Innovation and Growth

Under the new financial stewardship of Aman Kumar, Innoterra is poised to continue its mission of providing high-tech and human-touch services that disrupt traditional food value chains, connecting farmers to markets and enhancing capabilities through advisory programs. The company also holds patents for biological formulations and natural mutants against Panama disease, contributing to a total serviceable opportunity estimated at USD 1.5 billion. Operating across 11 geographies, Innoterra remains committed to pioneering solutions that promote a sustainable and prosperous future for agriculture.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This